Sofinnova Investments Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 22
Professionals
  • Investments
  • 284
  • Portfolio
  • 37
  • Exits
  • 181
Exits

Sofinnova Investments General Information

Description

Founded in 1974, Sofinnova Investments is a venture capital firm headquartered in Menlo Park, California. The firm seeks to invest in late preclinical and clinical therapeutic companies across the United States and Europe.

Contact Information

Website
www.sofinnova.com
Year Founded
1974
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Other Investor Types
PE/Buyout
Primary Office
  • 3000 Sand Hill Road, Building 4
  • Suite 250
  • Menlo Park, CA 94025
  • United States
+1 (650) 000-0000

Sofinnova Investments Investments (284)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Pyrowave 21-May-2021 Later Stage VC Machinery (B2B) Generating Revenue
000000000 26-Mar-2021 00000 00000 00000 Drug Discovery Clinical Trials - Phase 2 0000 000000 00.0
0000000 0000000000 20-Jan-2021 00000 00000 000.00 Biotechnology Clinical Trials - Phase 2 00000 00000 00
0000 000000000000 19-Jan-2021 00000 00000 0000 Drug Discovery Clinical Trials - General 0000 000000 00.0
00000 000000 08-Jan-2021 00000 00000 00000 Pharmaceuticals Generating Revenue
000000 00000000000 16-Dec-2020 00000 00000 0000 Drug Discovery Clinical Trials - General 00000 000000 00.0
00000000 000000000 06-Aug-2020 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 1 0000 000000 00.0
00000000 02-Jul-2020 00000 00000 00000 Drug Discovery Generating Revenue
Bolt Biotherapeutics 01-Jul-2020 Later Stage VC 000.00 Drug Discovery Generating Revenue/Not Profitable 00000 00000 00.0
Checkmate Pharmaceuticals 09-Jun-2020 Later Stage VC 000.00 Other Pharmaceuticals and Biotechnology Clinical Trials - Phase 2
You’re viewing 10 of 284 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sofinnova Investments Exits (181)

Company Name Exit Date Exit Type Exit Size
Vera Therapeutics 14-May-2021 IPO 000.00
000000 00000000000 28-Apr-2021 000000000000000000
0000000 0000000000 04-Mar-2021 000 00 00000000
0000 0000000000000 05-Feb-2021 000 00000
00000000 18-Dec-2020 000000000000000000 00.00
000000 00000000000 26-Oct-2020 000000 0000000000 000.00
000000000 00000000 28-Sep-2020 000000000000000000 00.000
000000 000000 18-Sep-2020 000 00000
Checkmate Pharmaceuticals 07-Aug-2020 IPO 0000
Inozyme Pharma 24-Jul-2020 IPO 00000
You’re viewing 10 of 181 exits. Get the full list »

Sofinnova Investments Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Sofinnova Investments‘s full profile, request access.

Request a free trial

Sofinnova Investments Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Sofinnova Investments Team (62)

Name Title Deals Funds Boards Office
James Healy MD Managing Partner 00 0 00 Menlo Park, CA
Michael Powell Ph.D General Partner 00 0 0 Menlo Park, CA
Lars Ekman Ph.D Executive Partner, Private Equity 0 0 0 Menlo Park, CA
David Kabakoff Ph.D Executive Partner, Private Equity 00 0 0 Menlo Park, CA
Nathalie Auber Partner & Chief Financial Officer Menlo Park, CA
You’re viewing 5 of 62 team members. Get the full list »

Sofinnova Investments Co-Investors (172)

Name With Exits Lead Partner Series Industry
Citadel (Hedge Fund) 7 0 0 Series chart Industry bar
Nan Fung Life Sciences 0 0 Series chart Industry bar
Novo Holdings 0 00 Series chart Industry bar
Canaan Partners 0 0 Series chart Industry bar
HBM Healthcare Investments 0 0 0 Series chart Industry bar
You’re viewing 5 of 172 co-investors. Get the full list »